首页|TCT联合HR-HPV检测在宫颈癌及癌前病变早期筛查中的应用价值

TCT联合HR-HPV检测在宫颈癌及癌前病变早期筛查中的应用价值

扫码查看
目的 探讨在宫颈癌及癌前病变早期筛查中选择液基薄层细胞检测(TCT)联合高危型人乳头状瘤病毒(HR-HPV)检测的实际价值及有效性.方法 选择2000例行宫颈癌及癌前病变早期筛查的患者,研究对象均取自2020年1月-2023年1月.均行TCT、HR-HPV检查.诊断金标准以病理结果为依据,对比TCT、HR-HPV单项及联合检测与病理结果的一致性.结果 病理检查结果显示,2000例患者中,阳性共396例,阴性共1604例.TCT+HR-HPV联合检测的灵敏度94.41%、特异性98.50%及准确率98.80%均明显高于TCT单项检测80.00%、87.83%、86.95%、HR-HPV单项检测82.10%、94.81%、92.40%,具统计学意义(P<0.05).TCT+HR-HPV检查的阳性、阴性预测值93.93%、98.62%明显高于TCT单项检测45.45%、97.19%和 HR-HPV 单项检测 78.78%、95.76%,误诊率、漏诊率 5.58%、1.51%明显低于 TCT 单项检测 20.00%、12.17%和HR-HPV单项检测17.89%、5.18%,具统计学意义(P<0.05).结论 通过TCT+HR-HPV检测进行宫颈癌及癌前病变早期筛查,可显著提升诊断准确率,有助于临床早期诊治,提升诊疗质量,且对患者生存周期具有延长作用.
Application value of TCT combined with HR-HPV detection in early screening of cervical cancer and precancerous lesions
Objective To explore the practical value and effectiveness of liquid-based thin-layer cell test(TCT)combined with high-risk human papillomavirus(HR-HPV)detection in the early screening of cervical cancer and precancerous lesions.Meth-ods 2000 patients with cervical cancer and precancerous lesions were selected for early screening from January 2020 to January 2023.TCT and HR-HPV were performed.The diagnostic gold standard was based on the pathological results,and the consistency be-tween the single and combined detection of TCT and HR-HPV and the pathological results was compared.Results Pathological ex-amination showed among 2000 patients,396 cases were positive and 1604 cases were negative.For TCT+HR-HPV combined detec-tion method,its sensitivity was 94.41%,its specificity was 98.50%and its accuracy was 98.80%.All data were significantly higher than those of TCT single detection which was 80.00%,87.83%and 86.95%respectively,and those of HR-HPV single detection which was 82.10%,94.81%and 92.40%respectively,and the difference was statistically significant(P<0.05).The positive and negative predic-tive values of TCT+HR-HPV were 93.93%and 98.62%,which were significantly higher than those of TCT single detection which was 45.45%,97.19%and those of HR-HPV single detection which was 78.78%and 95.76%.The misdiagnosis rate and missed diagnosis rate were 5.58%and 1.51%which were significantly lower than those of TCT single detection being 20.00%and 12.17%,and those of HR-HPV single detection which was 17.89%and 5.18%,and the difference was statistically significant(P<0.05).Conclu-sion Early screening of cervical cancer and precancerous lesions by TCT+HR-HPV detection can significantly improve the accu-racy of diagnosis,contribute to early clinical diagnosis and treatment,improve the quality of diagnosis and treatment,and prolong the survival period of patients.

TCTHR-HPV detectionCervical cancerPrecancerous lesionsEarly screeningDiagnostic accuracy

宋谦、赵淑珍、茅夏铭

展开 >

乌鲁木齐市中医医院,乌鲁木齐 830000

TCT HR-HPV检测 宫颈癌 癌前病变 早期筛查 诊断准确率

2024

新疆医学
新疆维吾尔自治区医学会

新疆医学

影响因子:0.385
ISSN:1001-5183
年,卷(期):2024.54(4)
  • 6